Anti-Cdc25C 抗体 [E302]
Anti-Cdc25C antibody [E302]
- RabMAb
- Recombinant
- KO Validated
- 詳細を見る
4
(3 Reviews)
|
(30 Publications)
Rabbit Recombinant Monoclonal Cdc25C antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Human samples. Cited in 30 publications.
別名を表示する
M-phase inducer phosphatase 3, Dual specificity phosphatase Cdc25C, CDC25C
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Cdc25C antibody [E302] (AB32444)
Immunocytochemistry/Immunofluorescence analysis of HeLa (human cervix adenocarcinoma) cells labelling Cdc25C with purified ab32444 at 1/400. Cells were fixed with 4% Paraformaldehyde and permeabilized with 0.1% Triton X-100. ab150077, Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000) was used as the secondary antibody. The cells were co-stained with ab7291, a mouse anti-tubulin antibody (1/1000) using ab150120, an Alexa Fluor® 594-conjugated goat anti-mouse IgG (1/1000) as the secondary. Nuclei couterstained with DAPI (blue).
For negative control 1, rabbit primary antibody was used, followed by anti-mouse secondary antibody (ab150120). For negative control 2, mouse primary antibody (ab7291) was used followed by anti-rabbit secondary antibody (ab150077).
- Flow Cyt (Intra)
AbReview31366****
Flow Cytometry (Intracellular) - Anti-Cdc25C antibody [E302] (AB32444)
Intracellular Flow Cytometry analysis of HeLa cells, staining Cdc25C with unpurified ab32444. Cells were fixed with formaldehyde and permeabilized with 90% methanol. Samples were incubated with primary antibody (1/20 in PBS + 10% goat serum) for 1 hour at 23°C. A FITC-conjugated goat anti-rabbit polyclonal IgG (1/1000) was used as the secondary antibody.
This image is courtesy of an Abreview submitted by Brandon White.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cdc25C antibody [E302] (AB32444)
Immunohistochemical analysis of paraffin-embedded human urinary bladder carcinoma unpurified ab32444 at 1/250 dilution.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cdc25C antibody [E302] (AB32444)
Immunohistochemical analysis of paraffin embedded human pancreas tissue section labelling Cdc25C with purified ab32444 at dilution of 1/2500. The secondary antibody used was Goat Anti-Rabbit IgG H&L (HRP) (ab97051), at dilution of 1/500. The sample was counter-stained with hematoxylin. Antigen retrieval was perfomed using Tris-EDTA buffer, pH 9.0. PBS was used instead of the primary antibody as the negative control and is shown in the inset.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Cdc25C antibody [E302] (AB32444)
Intracellular Flow Cytometry analysis of K562 (human chronic myelogenous leukemia) cells labelling Cdc25C with purified ab32444 at 1/180 (red). Cells were fixed with 4% paraformaldehyde. Alexa Fluorr® 488-conjugated goat anti-rabbit IgG (1/500) was used as the secondary antibody. Black - Isotype control, rabbit monoclonal IgG. Blue - Unlabelled control, cells without incubation with primary and secondary antibodies.
- IP
Unknown
Immunoprecipitation - Anti-Cdc25C antibody [E302] (AB32444)
ab32444 (purified) at 1/30 immunoprecipitating Cdc25C in HeLa (human cervix adenocarcinoma) whole cell lysate.
Lane 1 (input) : HeLa (human cervix adenocarcinoma) whole cell lysate
Lane 2 (+) : ab32444 + HeLa (human cervix adenocarcinoma) whole cell lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab32444 in HeLa (human cervix adenocarcinoma) whole cell lysate
For western blotting, ab131366 VeriBlot for IP Detection Reagent (HRP) was used for detection (1/10000).
Blocking buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM /TBST.
All lanes:
Immunoprecipitation - Anti-Cdc25C antibody [E302] (ab32444)
Predicted band size: 53 kDa
Observed band size: 60 kDa
false
- WB
Unknown
Western blot - Anti-Cdc25C antibody [E302] (AB32444)
Blocking and diluting buffer 5% NFDM/TBST
All lanes:
Western blot - Anti-Cdc25C antibody [E302] (ab32444) at 1/1000 dilution
All lanes:
HeLa (human cervix adenocarcinoma) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 53 kDa
Observed band size: 60 kDa
false
- WB
Lab
Western blot - Anti-Cdc25C antibody [E302] (AB32444)
Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : Cdc25C knockout HAP1 cell lysate (20 μg)
Lane 3 : HeLa cell lysate (20 μg)
Lane 4 : Hu bladder cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab32444 observed at 55 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab32444 was shown to recognize Cdc25C when Cdc25C knockout samples were used, along with additional cross-reactive bands. Wild-type and Cdc25C knockout samples were subjected to SDS-PAGE. ab32444 and ab8245 (loading control to GAPDH) were diluted at 1/2500 and 1/10 000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-Cdc25C antibody [E302] (ab32444)
Predicted band size: 53 kDa
false
- WB
Lab
Western blot - Anti-Cdc25C antibody [E302] (AB32444)
Lanes 1- 2 : Merged signal (red and green). Green - ab32444 observed at 58 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.
ab32444 was shown to react with Cdc25C in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab265189 (knockout cell lysate ab257387) was used. Wild-type HeLa and CDC25C knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab32444 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Cdc25C antibody [E302] (ab32444) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
CDC25C knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human CDC25C knockout HeLa cell line (<a href='/products/cell-lines/human-cdc25c-knockout-hela-cell-line-ab265189'>ab265189</a>)
Predicted band size: 53 kDa
Observed band size: 58 kDa
false
- WB
Unknown
Western blot - Anti-Cdc25C antibody [E302] (AB32444)
All lanes:
Western blot - Anti-Cdc25C antibody [E302] (ab32444) at 1/5000 dilution
All lanes:
HeLa cell lysate
Predicted band size: 53 kDa
Observed band size: 60 kDa
false
- WB
Unknown
Western blot - Anti-Cdc25C antibody [E302] (AB32444)
Blocking and diluting buffer 5% NFDM/TBST
All lanes:
Western blot - Anti-Cdc25C antibody [E302] (ab32444) at 1/5000 dilution
Lane 1:
K562 (human chronic myelogenous leukemia) whole cell lysate at 20 µg
Lane 2:
HEK293 (human embryonic kidney) whole cell lysates at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 53 kDa
Observed band size: 60 kDa
false
関連する標識済み抗体及び組成の異なる製品 (3)
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Cdc25C antibody [E302]
-
Anti-Cdc25C antibody [E302] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Cdc25C antibody [E302]
Reactivity data
製品の詳細
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The proper function of Cdc25C involves facilitating proper cell cycle progression by coordinating with other cell cycle regulators. It participates in a complex network where it dephosphorylates and activates CDK1/cyclin B1 complexes promoting the mitotic entry. This function is important for maintaining genomic stability during cell division. Misregulation of Cdc25C can lead to cell cycle arrest or uncontrolled cell proliferation highlighting its essential role in cell cycle control mechanisms.
Pathways
Cdc25C fits into the cell cycle checkpoint pathways and is also a part of the DNA damage response pathways. It connects with the p53 and ATM/ATR signaling proteins while responding to DNA damage ensuring a temporary pause in cell cycle progression for repair mechanisms to act. Proper interaction with these pathways is essential for maintaining cellular integrity and preventing the proliferation of damaged cells with CDK1 and Wee1 kinase serving as major interacting proteins in these processes.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (30)
Recent publications for all applications. Explore the full list and refine your search
Cancer cell international 25:100 PubMed40098146
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 14:1121799 PubMed37007025
2023
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineered 13:13089-13107 PubMed35615982
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of translational medicine 19:396 PubMed34544426
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 24: PubMed33907850
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 9:606106 PubMed33816462
2021
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 21:323 PubMed33692855
2021
Applications
Unspecified application
Species
Unspecified reactive species
Oncology reports 44:2152-2164 PubMed32901871
2020
Applications
Unspecified application
Species
Unspecified reactive species
International journal of genomics 2020:3750673 PubMed32509843
2020
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular medicine 45:1661-1672 PubMed32236619
2020
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com